Antigenics: Insider Buying Alert
I got word of two insider buys at Antigenics (AGEN) totaling 10,000 shares by a director:
The last time I wrote of an insider buy of AGEN was Sept. 2007 where the CEO bought 50,000 shares at an average price of $1.93. [See Insider Buying at AGEN by Chairman and CEO Garo H. Armen.] About 6 months later, the stock peaked at $3.90. I added to my position on Friday's news with the hope of selling into a similar advance. Details:
Director = Classification of Insider
JOHN HATSOPOULOS = Name
$17k = Value of I-Buy trade(s)
10k = Number of Shares
$1.71 = Average Price Paid
$1.68 = Recent Stock Price (delayed)
155k = Average Daily Volume (composite time frame)
$111M = Company Market Capitalization
2008-09-03 = Purchase Date
2008-09-05 = Filing Date
Key Info
0.89 = Beta
7.60% = Short Interest
15.9 = Short Ratio (days)
12-Aug-08 = Date of Above Short Information
I personally own AGEN as a long term investment and trade its volatility for added return. I also cover AGEN in "Kirk Lindstrom's Investment Newsletter." For my specific buy and sell targets, you need to Subscribe to Kirk's Investment Newsletter.
Warning:
AGEN is a very high risk stock because it has no profits and revenue is only 6 cents a share for a price-to-sales ratio of a whopping 29!
Related Articles
Related Stocks: |
Top Rated Comment Streams:
Numbers are net rating-
-
1.Hedged In661
- 2.
-
3.Smarty_Pants389
-
4.cos1000286
-
5.axelrod608273
More by Kirk Lindstrom
Most Popular
Most Read
Editors' Picks
Most Commented
-
Environmentalism May Face Major Setback in 2009 (82 comments)
-
Citigroup's Derivatives Reduce Bailout to a Non-Event (44 comments)
-
Sirius XM: An Equity Adrift (44 comments)
Investment Resources
Money Management
Research
Articles on related themes
Long Ideas
- Apple: A Question of Leadership Jan 06, 2009
- FMC Technologies: Positioned for a Deepwater Drilling Boom Jan 06, 2009
- Genentech's Trastuzumab-Dm1 Shows Great Promise in Treating Breast Cancer Jan 06, 2009
- Market Declines Offer Long-Term Buy Opportunities for the Strong of Stomach Jan 06, 2009
- Favoring the Up Side at the Start of the New Year Jan 06, 2009
- As Cellphones and Netbooks Converge Jan 06, 2009
- Chart of the Day: Bonds' Reversal Jan 06, 2009
- Nordic American Tanker: Be Prepared for Fluctuations Jan 06, 2009
- Walgreen: Cheap By Its Own Standards Jan 05, 2009
- 5 Small Cap Stocks for 2009 Jan 05, 2009
- Ratio of Gold to Silver Jan 05, 2009
- Datawatch: A Microcap Value Stock Jan 05, 2009
- Using the T2108 Indicator to Identify Overbought S&P 500 Conditions Jan 05, 2009
Biotech Diagnosis
- New Emerging Diagnostics Index Dec 26, 2008
- Myriad Genetics: A Healthy Performance in an Ailing Market Dec 22, 2008
- Meridian Bioscience Offers Immunization from Recession Dec 11, 2008
- Starting to Rebuild Genoptix Dec 03, 2008
- Two Compelling Small Caps for This Recession Nov 21, 2008
- Sequenom Misses, but Who Cares? Oct 30, 2008
- Expanding the Defensive Growth Index Into Europe Oct 23, 2008
- A Defensive Growth Stock Index Oct 21, 2008
- Sequenom Down on Threat of Competition Oct 07, 2008
- Genoptix: Turning Profitable with Solid Earnings Aug 24, 2008
- Sequenom: Genetic Testing Attracting Smart Money Aug 13, 2008
- ResMed Beats Earnings Estimates; Back on Track Aug 07, 2008
- Meridian Bioscience Update Jul 22, 2008
Biotech Equipment
- Giving Luminex the Benefit of the Doubt Dec 12, 2008
- JNJ / Omrix: Potential Synergies Nov 24, 2008
- Pharmas and Biotech: Vying for Outsize Insulin Profits Nov 20, 2008
- Key Quotes from Agilent on WIMAX, Semi-conductors and China Nov 19, 2008
- Earnings Preview: Agilent Technologies Aug 14, 2008
- Auxilium Gets A Testoserone Boost - Barron's Aug 10, 2008
- Invitrogen: Stock Will Keep Rising May 04, 2008
- Noveko Signs Deal to Distribute Surgical Face Masks Apr 06, 2008
- Stent Market: Going Through a Shakeup Mar 28, 2008
- China Medical Technologies' Transition is Well Underway Mar 26, 2008
- Interview with Ron Andrews, President & CEO of Clarient Mar 17, 2008
- Despite Good News, Noveko Shares Continue to Fall Mar 11, 2008
- Earnings Preview: Agilent Technologies Feb 13, 2008
Biotech Research
- Momenta Pharma's Opportunities Abound Jan 04, 2009
- Updated FDA Decision Calendar: Five Decisions Before Year-End Dec 28, 2008
- Five Healthcare Stocks Positioned for a Happy New Year Dec 23, 2008
- 40 Top Rated Emerging Bio-Pharma Stocks Dec 23, 2008
- FDA Calendar Update: High Hopes for Amgen's Bone Drug Dec 21, 2008
- Stem Cell and Regenerative Medicine Stocks Surge in December Dec 20, 2008
- Healthcare: Investing Trends for 2009 Dec 19, 2008
- Trading on FDA Decisions: BioDelivery Sciences Could Have a Big '09 Dec 16, 2008
- Updated FDA Calendar: Cypress Bioscience Looks Like a Buy Dec 12, 2008
- Nine for '09: Staying Defensive in the New Year Dec 11, 2008
- Taro Pharma Tender Raises Questions About Rival Company Valuations Dec 10, 2008
- Looking for Laggards After the Latest Market Rally Dec 09, 2008
- Cytori Therapeutics and Cypress Bio: Two Buys Based on Positive Trial Results Dec 09, 2008
- Free E-Newsletters
- Wall Street Breakfast -Sample
Wall Street Breakfast: Must-Know Newsby SA Editor Rachael Granby- Bank trio becomes duo. Wells Fargo (WFC) will become the largest U.S. bank by branches with its bid for Wachovia (WB), after Citigroup (C) withdrew from compromise negotiations late yesterday on concerns about the quality of some of Wachovia's assets. Wells Fargo, with a bid valued at $11.4B, expects the purchase to be completed by the end of the year, and denies it will have to absorb assets shakier than originally thought.
- Government considers next steps. As the financial crisis continues to worsen, the U.S. government is considering two dramatic steps to turn around, or at least slow, the damage: guaranteeing billions of dollars in bank debt and temporarily insuring all U.S. bank deposits. The moves, which would mark the government's most extensive intervention to date, are in discussion stages only.
- Credit stays frozen. As frozen credit markets refuse to thaw, the cost of default protection on corporate bonds reaches new global records amid investor concerns the credit crisis will trigger corporate failures as companies struggle to finance their businesses. Interbank lending remains limited, and borrowing from the Fed's expanded discount window continued its trend of setting new highs every week, as the total daily average rose to $420.2B vs. $367.8B last week.
- Oil demand withers. The International Energy Agency warned Friday worldwide oil demand...
- The Macro View -SampleSeeking Alpha - The Macro ViewMarket Outlook
- An Outcry from Emerging and Developed Markets Alike by Jonathan O'Shaughnessy
- Long Term, Financials Look Good by Michael Filloon
- Round 3 of the Recession: Main Street by Paul Fekula
Oil Price- Oil Below $75: Increased Chance of OPEC Production Cuts by Money Morning
- Oil Down 48% from Highs by Bespoke Investment Group
- Oil & Gas Headed Lower as Economy Strikes Consumers by Michael Filloon
Economy- Long Term, Financials Look Good by Michael Filloon
- Round 3 of the Recession: Main Street by Paul Fekula
- Reality Bites As Stocks Continue To Collapse by The Mole
- Investing Ideas -SampleSeeking Alpha - Investing IdeasCramer's Picks
- Farewell Financial Bear Raids - Cramer's Mad Money (10/14/08) by SA Editor Joan Wickham
- Better Picks - Cramer's Lightning Round (10/14/08) by SA Editor Joan Wickham
- Perhaps Industrials... Cramer's Stop Trading! (10/14/08) by SA Editor Joan Wickham
Long Ideas- Utilities Beginning to Generate Interest for Longs by Joe Kunkle
- The Long Case for Encore Capital by Value Investor Insight
- 2009: The Year of the Channel for SaaS Vendors? by Jeff Kaplan
- Two Global Infrastructure Investment Opportunities in ETFs by Investment U
- Market Behaves Sanely - Fast Money Recap (10/14/08) by SA Editor Joan Wickham
Short Ideas- Why Short Sellers Are the Heroes of Wall Street by Investment U
- Salesforce.com: Pricey and Coming Down Fast by Charlie Bottle
- Google: 3Q Results Reveal Chinks in the Armor by Mark Krieger
- Jim Cramer's Picks -SampleBetter Choices - Cramer's Lightning Round (10/15/08)by SA Editor Rachael GranbyStocks discussed in the lightning round session of Jim Cramers Mad Money TV program,
Wednesday, October 15.Bullish Calls:Continental Resources (CLR) -- "This is a remarkable decline. All of the high quality ones are down so much, I can't go against it. This is where you pull the trigger.
3M (MMM) -- The moment this stock starts yielding 5%, I'm a buyer. Until then, keep your powder dry.Bearish Calls:Computer Sciences (CSC) -- This is a company that was going to be bought, but they passed up the chance. Now I don't want to buy it."Email continues...
Annaly Mortgage (NLY) -- I think this is a business model that needs to borrow money. Definitively do not buy."
Northrop Grumman (NOC) -- You can't own the defense stocks right now. If I had to own one, I'd look at Lockheed Martin (LMT) with its good dividend. - Stocks & Sectors -SampleSeeking Alpha - Stocks & SectorsInternet
- eBay: Q3 Looks Good but Q4 Guidance Disappoints by Greg Feirman
- Is Google Feeling Lucky? by Sam Gustin
- Why Today Could Suck for Tech by Kevin Maney
Media- A Triple Financial Whammy Afflicts Newspapers by Ken Doctor
- Three Years On, Buying MySpace Looks Like One of Murdoch's Smartest Bets by Erick Schonfeld
- How Will Arbitron Fare in This Market? by Sreeni Meka
Telecom- Ten Ways to Invest in Louisiana by Stockerblog
- Earnings Preview: Electro-Optical Engineering by theflyonthewall.com
- Shared Docks Via WiFi All the Rage by Dean Bubley
Financial- Switzerland Strengthens Its Banks; Short Interest Remains Low by Jessica Johnson
- Reality Bites As Stocks Continue To Collapse by The Mole
- LIBOR Shows Worst Is Yet to Come for Credit Markets by Keith Fitz-Gerald
- Global Markets -SampleSeeking Alpha - Global MarketsChina
- An Outcry from Emerging and Developed Markets Alike by Jonathan O'Shaughnessy
- USANA Health Sciences Inc. Q3 2008 Earnings Call Transcript
- Perfect World Announces Share Repurchase Program by Trader Mark
- China: Hot Money Inflows Down, Nervousness Up by Michael Pettis
India- Indian Economy Has Much to Cheer About by Equitymaster
- India: RBI Cuts Cash Reserve Ratio by Equitymaster
- India: Markets Continue Downward by Equitymaster
Japan- Sanyo Enters Thin-Film Market, Goes Up Against Sharp by Greentech Media
Asia- Four International Dividend Stocks to Watch by David Hunkar
Eastern Europe- Reality Bites As Stocks Continue To Collapse by The Mole
- Alternative Energy Investing -SampleSeeking Alpha - Alternative EnergyAlternative Energy
- Seven Stocks for an Impending Apocalypse by H.J. Huneycutt
- Solar Shares Under Pressure From Credit Crunch and Pricing by Eric Savitz
- Trina Solar Looks Good, Though Market Yawns by Trader Mark
- The Electric Car Market: Wise Energy Use Stocks by Tom Konrad
- Investing in the Power of the Sea
- ETF Daily -SampleSeeking Alpha - ETF DailySector ETFs
- Too Early To Buy Homebuilders ETF by Larry MacDonald
- Utilities Beginning to Generate Interest for Longs by Joe Kunkle
- Two Global Infrastructure Investment Opportunities in ETFs by Investment U
New ETFs- First Trust Launches Infrastructure ETF with Global Reach by Index Universe
- Overview and Analysis of the Global Generic Drug Industry by Mike Havrilla
Emerging Market ETFs- Brazil Is the Best of BRIC by Carl T. Delfeld
- Playing the Market in Difficult Times by Jason Hamlin
- The Daily Dispatch -SampleSeeking Alpha - Daily DispatchWall Street Breakfast
- Wall Street Breakfast: Must-Know News by SA Editor Rachael Granby
US Market- An Outcry from Emerging and Developed Markets Alike by Jonathan O'Shaughnessy
- Wall Street Breakfast: Must-Know News by SA Editor Rachael Granby
Housing & Real Estate- Too Early To Buy Homebuilders ETF by Larry MacDonald
- Another 'Root Cause' That Isn't: Tumbling Home Prices by Tim Iacono
Transcripts- TrueBlue, Inc. Q3 2008 Earnings Call Transcript
- Polycom, Inc. Q3 2008 Earnings Call Transcript
ETF- Too Early To Buy Homebuilders ETF by Larry MacDonald
- About Seeking Alpha
- About Us
- Contact Us
- What's New
- Readers Feedback
- Advertise With Us
- Contributors
- Contribute an Article
- Feature Your Book
- Our Contributors
- Anonymous Contributions
- Dispute an Article?
- Legal
- Terms of Use
- Privacy
- Copyright




This article has 3 comments:
-
Jakester
-
37 Comments
Sep 07 12:30 PM-
Kirk Lindstrom
-
30 Comments
My Website
Sep 08 10:24 AM"GE: General Electric's CEO Immelt Invests Another $5 Million Of His Own Money In GE Stock"
kirklindstrom.blogspot...
I'm not recommending this as a long term, major buy... but I like to tag along when insiders are buying if possible.
Check out the insider buying vs selling here:
www.secform4.com/insid...
Compare that with Cisco
www.secform4.com/insid...
a stock I won't own since insiders have no confidence in it...
-
CrossProfit
-
567 Comments
My Website
Sep 09 05:48 AMThis means that any possible sale of the company is 60 days off.
CrossProfit
www.crossprofit.com